Medinotec (MDNC) Operating Leases (2024 - 2026)

Medinotec (MDNC) posted Operating Leases of $8829.0 for Q2 2026, up 10.17% on a QoQ basis from $8014.0 in Q2 2025, and up 10.17% year-over-year from $8014.0 in Q2 2025.

Medinotec (MDNC) Operating Leases (2024 - 2026) Analysis & Trends

Medinotec's Operating Leases history runs 3 years deep, the most recent figure standing at $8829.0 for Q2 2026.

  • Quarterly Operating Leases rose 10.17% year-over-year to $8829.0 in Q2 2026, while the trailing twelve-month figure through May 2026 was $8829.0 (up 10.17% YoY) and the FY2025 annual result came in at $12696.0, down 68.02% from the prior year.
  • Operating Leases was $8829.0 for Q2 2026 at Medinotec, up from $8014.0 in the prior quarter.
  • Across five years, Operating Leases topped out at $39698.0 in Q1 2024 and bottomed at $8014.0 in Q2 2025.
  • A 3-year average of $21756.4 and a median of $20731.0 in 2024 frame the typical range for Operating Leases.
  • Annual changes were most pronounced in 2025 — Operating Leases tumbled 76.34% — and 2026, when it advanced 10.17%.
  • Medinotec's Operating Leases stood at $20731.0 in 2024, then plunged by 61.34% to $8014.0 in 2025, then climbed by 10.17% to $8829.0 in 2026.
  • Business Quant data shows MDNC's Operating Leases at $8829.0 in Q2 2026, $8014.0 in Q2 2025, and $12696.0 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 182.52 Bn 175.22 Bn 6.27 Bn
2 Stryker 128.96 Bn 126.09 Bn 3.81 Bn
3 Medtronic 107.99 Bn 98.77 Bn 6.41 Bn
4 Boston Scientific 67.76 Bn 66.31 Bn 3.61 Bn
5 Edwards Lifesciences 48.09 Bn 44.41 Bn 1.29 Bn
6 Dexcom 28.30 Bn 27.18 Bn 750.30 Mn
7 GE HealthCare Technologies 27.89 Bn 25.61 Bn 1.98 Bn
8 Smith & Nephew 27.02 Bn 26.45 Bn -
9 Koninklijke Philips 23.98 Bn 20.86 Bn 2.07 Bn
10 Medinotec 58.78 Mn 58.19 Mn 1.31 Mn

Historic Data

Download Data
DateValue
May 31, 2026 8,829.00
May 31, 2025 8,014.00
Feb 28, 2025 12,696.00
Nov 30, 2024 20,731.00
Aug 31, 2024 28,454.00
May 31, 2024 33,873.00
Feb 29, 2024 39,698.00